Literature DB >> 34816288

C-reactive protein rise in response to macronutrient deficit early in critical illness: sign of inflammation or mediator of infection prevention and recovery.

Ilse Vanhorebeek1, Greet Van den Berghe1, Catherine Ingels2, Lies Langouche1, Jasperina Dubois3, Inge Derese1, Sarah Vander Perre1, Pieter J Wouters1, Jan Gunst1, Michaël Casaer1, Fabian Güiza1.   

Abstract

PURPOSE: Withholding parenteral nutrition (PN) early in critical illness, late-PN, has shown to prevent infections despite a higher peak C-reactive protein (CRP). We investigated whether the accentuated CRP rise was caused by a systemic inflammatory effect mediated by cytokines or arose as a consequence of the different feeding regimens, and whether it related to improved outcome with late-PN.
METHODS: This secondary analysis of the EPaNIC-RCT first investigated, with multivariable linear regression analyses, determinants of late-PN-induced CRP rise and its association with cytokine responses (IL-6, IL-10, TNF-α) in matched early-PN and late-PN patients requiring intensive care for ≥ 3 days. Secondly, with multivariable logistic regression and Cox proportional-hazard analyses, we investigated whether late-PN-induced CRP rises mediated infection prevention and enhanced recovery or reflected an adverse effect counteracting such benefits of late-PN.
RESULTS: CRP peaked on day 3, higher with late-PN [216(152-274)mg/l] (n = 946) than with early-PN [181(122-239)mg/l] (n = 946) (p < 0.0001). Independent determinants of higher CRP rise were lower carbohydrate and protein intakes (p ≤ 0.04) with late-PN, besides higher blood glucose and serum insulin concentrations (p ≤ 0.01). Late-PN did not affect cytokines. Higher CRP rises were independently associated with more infections and lower likelihood of early ICU discharge (p ≤ 0.002), and the effect size of late-PN versus early-PN on these outcomes was increased rather than reduced after adjusting for CRP rise, not confirming a mediating role.
CONCLUSIONS: The higher CRP rise with late-PN, explained by the early macronutrient deficits, did not relate to cytokine responses and thus did not reflect more systemic inflammation. Instead of mediating clinical benefit on infection or recovery, the accentuated CRP rise appeared an adverse effect reducing such late-PN benefits.
© 2021. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  CRP; Critical illness; Cytokines; Early macronutrient restriction; Infection; Inflammation

Mesh:

Substances:

Year:  2021        PMID: 34816288     DOI: 10.1007/s00134-021-06565-1

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  47 in total

Review 1.  C-reactive protein: a valuable marker of sepsis.

Authors:  Pedro Póvoa
Journal:  Intensive Care Med       Date:  2002-02-06       Impact factor: 17.440

Review 2.  C-reactive protein: a critical update.

Authors:  Mark B Pepys; Gideon M Hirschfield
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

Review 3.  Pentraxins in humoral innate immunity.

Authors:  Antonio Inforzato; Barbara Bottazzi; Cecilia Garlanda; Sonia Valentino; Alberto Mantovani
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 4.  An overview of cytokines and heat shock response in polytraumatized patients.

Authors:  Maria Concepción Guisasola; Berta Alonso; Beatriz Bravo; Javier Vaquero; Francisco Chana
Journal:  Cell Stress Chaperones       Date:  2017-11-03       Impact factor: 3.667

5.  Early versus late parenteral nutrition in critically ill adults.

Authors:  Michael P Casaer; Dieter Mesotten; Greet Hermans; Pieter J Wouters; Miet Schetz; Geert Meyfroidt; Sophie Van Cromphaut; Catherine Ingels; Philippe Meersseman; Jan Muller; Dirk Vlasselaers; Yves Debaveye; Lars Desmet; Jasperina Dubois; Aime Van Assche; Simon Vanderheyden; Alexander Wilmer; Greet Van den Berghe
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

6.  Negative impact of hypocaloric feeding and energy balance on clinical outcome in ICU patients.

Authors:  Stéphane Villet; René L Chiolero; Marc D Bollmann; Jean-Pierre Revelly; Marie-Christine Cayeux R N; Jacques Delarue; Mette M Berger
Journal:  Clin Nutr       Date:  2005-08       Impact factor: 7.324

Review 7.  Enteral vs. parenteral nutrition for the critically ill patient: a combined support should be preferred.

Authors:  Claudia-Paula Heidegger; Patrice Darmon; Claude Pichard
Journal:  Curr Opin Crit Care       Date:  2008-08       Impact factor: 3.687

8.  ESPEN Guidelines on Parenteral Nutrition: intensive care.

Authors:  Pierre Singer; Mette M Berger; Greet Van den Berghe; Gianni Biolo; Philip Calder; Alastair Forbes; Richard Griffiths; Georg Kreyman; Xavier Leverve; Claude Pichard
Journal:  Clin Nutr       Date:  2009-06-07       Impact factor: 7.324

Review 9.  Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3.

Authors:  Alberto Mantovani; Cecilia Garlanda; Andrea Doni; Barbara Bottazzi
Journal:  J Clin Immunol       Date:  2007-09-09       Impact factor: 8.317

Review 10.  Neonatal sepsis and inflammatory mediators.

Authors:  Juliana Reis Machado; Danilo Figueiredo Soave; Marcos Vinícius da Silva; Liliana Borges de Menezes; Renata Margarida Etchebehere; Maria Luiza Gonçalves dos Reis Monteiro; Marlene Antônia dos Reis; Rosana Rosa Miranda Corrêa; Mara Rúbia Nunes Celes
Journal:  Mediators Inflamm       Date:  2014-12-30       Impact factor: 4.711

View more
  2 in total

1.  C-reactive protein in immunometabolism: spared from 'paying the piper'.

Authors:  Zudin Puthucheary; Jean-Marc Tadié; Jayshil J Patel
Journal:  Intensive Care Med       Date:  2021-11-26       Impact factor: 17.440

2.  Medical nutrition therapy and clinical outcomes in critically ill adults: a European multinational, prospective observational cohort study (EuroPN).

Authors:  Wolfgang H Hartl; Michael Hiesmayr; Martin Matejovic; Olivier Huet; Karolien Dams; Gunnar Elke; Clara Vaquerizo Alonso; Akos Csomos; Łukasz J Krzych; Romano Tetamo; Zudin Puthucheary; Olav Rooyackers; Inga Tjäder; Helmut Kuechenhoff
Journal:  Crit Care       Date:  2022-05-18       Impact factor: 19.334

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.